Afr J Reprod Health

1. LI Y, Wang H, Yang J, Wang H, et al
   Triage accuracy of a six-gene methylation detection for high-risk HPV-positive Chinese women.
   Afr J Reprod Health. 2025;29:137-147.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

2. LEVIN G, Monk BJ, Pothuri B, Coleman R, et al
   Racial and ethnic enrollment disparities in clinical trials leading to FDA approvals for gynecologic malignancies.
   Am J Obstet Gynecol. 2025 Jan 23:S0002-9378(25)00048.
   

   >> Share

   
   

   
   Ann Epidemiol

3. MA Z, Liu M, Yuan Q, Tang Z, et al
   Differences in Cervical Cancer Stage at Diagnosis and Survival Outcomes Among Asian, Native Hawaiian, and Other Pacific Islander Patients and White Patients.
   Ann Epidemiol. 2025 Jul 23:S1047-2797(25)00209.
   

   >> Share

   
   

   
   Arch Gynecol Obstet

4. MARTIN TM, Castro CC, Glickman A, Carreras N, et al
   Sentinel lymph node biopsy versus pelvic lymphadenectomy for early-stage cervical cancer: a retrospective institutional review.
   Arch Gynecol Obstet. 2025 Jul 31. doi: 10.1007/s00404-025-08134.
   

   >> Share

   
   

   
   Arch Med Sci

5. RZYMSKA A, Kycler W, Muszynska M, Rzymski P, et al
   Limited confidence in cervical cancer screening - unusually increased carcinoembryonic antigen expression resulting in the rapid development of cervical intraepithelial neoplasia grade 2.
   Arch Med Sci. 2025;21:1073-1076.
   

   >> Share

   
   

   
   Asian Pac J Cancer Prev

6. SALIH SR, Abdulla KN, K Awn A, Yasin YS, et al
   Impact of Esomeprazole, Ciprofloxacin and Their Combination on Cervical Cancer Cell Line Proliferation: A Focus on Heat Shock Protein 70 Modulation.
   Asian Pac J Cancer Prev. 2025;26:2455-2466.
   

   >> Share

   
   
7. IROWA O, Adeyeye OS, Ogwuche PE, Otache AE, et al
   Knowledge Attitude and Determinants of Cervical Cancer Screening Uptake Among Age-Eligible Women and Male Partners in Makurdi North-Central Nigeria.
   Asian Pac J Cancer Prev. 2025;26:2389-2396.
   

   >> Share

   
   
8. DOGAN NU, Dogan S
   New Surgical Techniques for Early Stage Cervical Cancer Under 2 cm : Is There Enough Evidence?
   Asian Pac J Cancer Prev. 2025;26:2319-2325.
   

   >> Share

   
   

   
   Biochem Biophys Rep

9. JIAO L, Gao Y
   miR-21-5p inhibitor enhances the radiosensitivity of human cervical cancer cells via blocking CPEB3-mediated CDK1/cyclin B pathway.
   Biochem Biophys Rep. 2025;43:102177.
   

   >> Share

   
   

   
   Bioengineering (Basel)

10. GIANSANTI D, Lastrucci A, Pirrera A, Villani S, et al
    AI in Cervical Cancer Cytology Diagnostics: A Narrative Review of Cutting-Edge Studies.
    Bioengineering (Basel). 2025;12:769.
    

    >> Share

    
    

    
    Biomedicines

11. MERDZHANOVA-GARGOVA Y, Ivanova M, Mollova-Kysebekirova A, Mihaylova A, et al
    Advancements in Cervical Cancer Screening: Enhancing HPV Testing and Triage Strategies for Improved Risk Assessment.
    Biomedicines. 2025;13:1768.
    

    >> Share

    
    

    
    Biosens Bioelectron

12. LONG Y, Yu T, Shi D, Song L, et al
    T7-assisted special rolling circular amplification platform for point-of-care cervical cancer screening.
    Biosens Bioelectron. 2025;288:117831.
    

    >> Share

    
    

    
    BJOG

13. ELLIS LB, Bowden SJ, Lyons D, Kyrgiou M, et al
    SIP 7: Progress in Cervical Cancer Prevention in the UK (2025 Second Edition).
    BJOG. 2025 Jul 30. doi: 10.1111/1471-0528.18262.
    

    >> Share

    
    

    
    BMC Cancer

14. YAO X, Qie M, Kang L, Li M, et al
    Assessing the risk of undetected cervical cancer in women with a biopsy of high-grade cervical intraepithelial neoplasia: predictive value of cytology and endocervical curettage (ECC).
    BMC Cancer. 2025;25:1238.
    

    >> Share

    
    

    
    BMC Public Health

15. SULTANOV M, de Bock GH, Koot JAR, de Zeeuw J, et al
    High-risk human papillomavirus testing for underscreened populations: cost-effectiveness and affordability in three country settings.
    BMC Public Health. 2025;25:2570.
    

    >> Share

    
    
16. YESILFIDAN D, Ozkan M, Adana F
    Comparison of cervical Cancer-Related knowledge, attitudes, and behaviors among women in urban and rural regions.
    BMC Public Health. 2025;25:2561.
    

    >> Share

    
    
17. CHAPOLA JC, Chinula L, Dunda W, Bula A, et al
    Exploring perceived barriers and facilitators to using mobile phone technology for delivering HPV test results in malawi: a qualitative study with HPV-Screened women, healthcare providers, and health officials.
    BMC Public Health. 2025;25:2563.
    

    >> Share

    
    

    
    BMC Res Notes

18. BAZMI H, Asghari AA, Jalali MB, Rezvan L, et al
    Upregulation of PCAT1, PCAT2, and PCAT3 LncRNAs in cervical cancer patients and their diagnostic value.
    BMC Res Notes. 2025;18:326.
    

    >> Share

    
    

    
    BMC Womens Health

19. WANG ZT, Dang CW, You RL, Li S, et al
    Age-period-cohort analysis of global, regional, and national cervical cancer prevalence trends in women of childbearing age (15-49 years), 1990-2021.
    BMC Womens Health. 2025;25:374.
    

    >> Share

    
    
20. NIE F, Si H, Qin H, Wang Y, et al
    Cervical and vaginal metastases from ascending colon cancer: a case report and literature review.
    BMC Womens Health. 2025;25:369.
    

    >> Share

    
    

    
    BMJ Open

21. DESTAW A, Getachew S, Getachew E, Shita A, et al
    Follow-up rescreening uptake and persistent positive rates among women after positive cervical cancer screening results in Ethiopia: a longitudinal cross-sectional study.
    BMJ Open. 2025;15:e099955.
    

    >> Share

    
    

    
    Cancer Epidemiol Biomarkers Prev

22. HUDDLESTON C, Mani C, Sah N, Courtney E, et al
    Evaluating Efficacy of Cervical HPV-HR DNA Testing as Alternative to PET/CT Imaging for Posttreatment Cancer Surveillance: Retrospective Proof-of-Concept Study.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1264-1268.
    

    >> Share

    
    

    
    Cancer Med

23. NIU J, Sasidharan S
    Development of a Mitochondrial Permeability Transition-Driven Necrosis-Related Prognostic Signature in Cervical Cancer: Integrating Bulk Transcriptomic and Single-Cell Data.
    Cancer Med. 2025;14:e71094.
    

    >> Share

    
    

    
    Cancer Prev Res (Phila)

24. LI Y, Qin C, Li KT, He Y, et al
    Feasibility and Acceptability of Pay-it-forward in Increasing Uptake of HPV Vaccination among 15- to 18-Year-Old Girls in China: Pilot RCT Results.
    Cancer Prev Res (Phila). 2025;18:485-492.
    

    >> Share

    
    

    
    Cell Death Dis

25. SUN Q, Yang Z, Li P, Wang X, et al
    Retraction Note to: A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-kappaB and TIMP3/MMP9 pathways in cervical cancer cells.
    Cell Death Dis. 2025;16:569.
    

    >> Share

    
    

    
    Cell Oncol (Dordr)

26. WANG S, Mao Z, Liu Y, Lan C, et al
    Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer.
    Cell Oncol (Dordr). 2025 Jul 28. doi: 10.1007/s13402-025-01092.
    

    >> Share

    
    

    
    Clinics (Sao Paulo)

27. ARAI RJ, da Costa TR, Bonadio RC, Ferreira S, et al
    Exploratory unsupervised machine learning of angiogenesis biomarkers in a phase II advanced cervical cancer trial of radiochemotherapy with or without neoadjuvant chemotherapy.
    Clinics (Sao Paulo). 2025;80:100723.
    

    >> Share

    
    

    
    Curr Pharm Biotechnol

28. SHARMA S, Mishra A, Pandey P, Verma M, et al
    Emerging Protein Therapeutics as a Strategy for Cervical Cancer Treatment.
    Curr Pharm Biotechnol. 2025 Jul 25. doi: 10.2174/0113892010397753250704105423.
    

    >> Share

    
    

    
    Discov Oncol

29. CAI Y, Jiang N, Wang Y, Ji M, et al
    Association and interaction network analysis of immune cell subgroups in cervical cancer microenvironment based on Mendelian randomization.
    Discov Oncol. 2025;16:1412.
    

    >> Share

    
    

    
    Eur J Obstet Gynecol Reprod Biol

30. FERREIRA MCP, Sebastiao APM, Zanine RM
    The risk of recurrence of high-grade squamous intraepithelial lesions and its association with the number of colposcopic biopsies.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114554.
    

    >> Share

    
    

    
    Eur J Public Health

31. PEREIRA SDG, Nobre L, Ribeiro M, Carvalho P, et al
    Targeting under-screened women in cervical cancer: combining self-sampling and human papillomavirus testing with a strategic reminder plan.
    Eur J Public Health. 2025 Jul 28:ckaf122. doi: 10.1093.
    

    >> Share

    
    

    
    Expert Opin Biol Ther

32. NISHIO S
    Bintrafusp alfa and its unsuccessful development journey towards cervical cancer treatment.
    Expert Opin Biol Ther. 2025 Jul 30:1-3. doi: 10.1080/14712598.2025.2541795.
    

    >> Share

    
    

    
    Food Chem Toxicol

33. LI W, Wang M, Du P, Han A, et al
    CDDO-Me triggers ROS-dependent ferroptosis and apoptosis in cervical cancer via targeting PI3K/Nrf2 pathway.
    Food Chem Toxicol. 2025;204:115664.
    

    >> Share

    
    

    
    Front Cell Infect Microbiol

34. KAWASAKI R, Kukimoto I, Nishio E, Otani S, et al
    Distinct cervical microbiome and metabolite profiles before and after menopause: implications for cervical cancer progression.
    Front Cell Infect Microbiol. 2025;15:1589277.
    

    >> Share

    
    

    
    Front Immunol

35. CHEN J, Yu H, Lin Y, Hu D, et al
    Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study.
    Front Immunol. 2025;16:1611696.
    

    >> Share

    
    

    
    Gac Med Mex

36. MARTINEZ-CASTILLO MA, Cueto MAH, Taniguchi-Ponciano K, Salcedo M, et al
    RET could act as suppressor tumor gene in cervical cancer cells.
    Gac Med Mex. 2025;161:132-139.
    

    >> Share

    
    

    
    Gynecol Oncol Rep

37. KERNELL CG, Kassick M, George JM, Anakwenze CP, et al
    Assessing delays in accessing and completing radiotherapy for cervical cancer treatment: A multicenter survey of oncology providers in go further-funded countries in Sub-Saharan Africa.
    Gynecol Oncol Rep. 2025;60:101810.
    

    >> Share

    
    

    
    Health Equity

38. SINGH S, Mehta N, Noh M, Bond K, et al
    Weight-Based Health Care Discrimination and Cervical Cancer Screening Among Black Sexual and Gender Minoritized Assigned Female at Birth Adults in the United States.
    Health Equity. 2025;9:22-30.
    

    >> Share

    
    

    
    Health Expect

39. WHITLEY S, Hawkins RL, Davies JC, Cao J, et al
    Acceptability of Self-Sampling for Cervical Screening in Ethnically Diverse Groups in Northwest England: A Focus Group Study.
    Health Expect. 2025;28:e70338.
    

    >> Share

    
    

    
    Health Policy Plan

40. OKOLIE EA, Beek K, Patel B, Ndikom CM, et al
    Cervical Cancer Prevention and Control in Nigeria: Mapping and review of policies.
    Health Policy Plan. 2025 Jul 30:czaf049. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Environ Res Public Health

41. QUINTANA GR, Herrera N, Santibanez-Palma JF, Escudero-Pasten J, et al
    Psychometric Evidence of the Pap Smear Test and Cervical Cancer Beliefs Scale (CPC-28) in Aymara Women from Chile.
    Int J Environ Res Public Health. 2025;22:1025.
    

    >> Share

    
    
42. MBONA SV, Ananth A, Chifurira R
    A Bayesian Logistic Regression Approach to Investigating the Determinants Associated with Never Having Been Screened for Cervical Cancer Amongst Child-Bearing-Age Women in Jordan.
    Int J Environ Res Public Health. 2025;22:1000.
    

    >> Share

    
    

    
    Int J Epidemiol

43. LOFLING LL, Stoer NC, Botteri E, Fortner RT, et al
    Statins and the risk of gynecological cancer: a Norwegian population-based cohort study.
    Int J Epidemiol. 2025;54:dyaf133.
    

    >> Share

    
    

    
    Int J Gynaecol Obstet

44. MORA-SOTO N, Morante-Caicedo C, Caicedo-Martinez M, Viveros-Carreno D, et al
    Morbidity of radical surgery and postoperative radiotherapy in cervical cancer.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70281.
    

    >> Share

    
    
45. LI Z, Wang P, Lu D, Ding Z, et al
    Development and validation of a risk prediction model for lower limb lymphedema in postoperative cervical cancer patients.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70423.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

46. HAGEN KK, Lie AK, Dahl GF, Eyjolfsdottir B, et al
    The Silva pattern-based classification and oncological outcomes in women undergoing fertility-sparing surgery for early-stage cervical cancer.
    Int J Gynecol Cancer. 2025;35:102012.
    

    >> Share

    
    

    
    Int J Mol Sci

47. AGNANTI E, Tsakogiannis D, Papadopoulos T, Arvanitidis KI, et al
    Disruption Events in the HPV18 E1 and E2 Genes in Precancerous Cervical Lesions.
    Int J Mol Sci. 2025;26:6974.
    

    >> Share

    
    

    
    Int J Surg

48. SONG T, Chen X, Chen F, Wan Q, et al
    Unraveling the prognostic puzzle: in-depth exploration of lymph node metrics for surgically treated FIGO stage IB-IIA cervical cancer-focus on the number of positive lymph nodes and the lymph node ratio.
    Int J Surg. 2025 Jul 15. doi: 10.1097/JS9.0000000000003033.
    

    >> Share

    
    

    
    J Cancer Educ

49. LI D, Zhang W, Stinson J, Jibb L, et al
    Navigating HPV Vaccination: a Qualitative Study on Chinese Women's Decision-Making Experiences.
    J Cancer Educ. 2025;40:616-625.
    

    >> Share

    
    

    
    J Health Organ Manag

50. KIRAN S, Akbolat M
    Perceived barriers and facilitators in access to breast and cervical cancer screening: a qualitative exploration among women in Trabzon, Turkey.
    J Health Organ Manag. 2025 Aug 1:1-17. doi: 10.1108/JHOM-12-2024-0503.
    

    >> Share

    
    

    
    J Obstet Gynaecol Res

51. MIZUTA Y, Yamanoi K, Miyamoto T, Mizuno R, et al
    Therapeutic impact of neoadjuvant chemotherapy on lymph node metastasis in locally advanced cervical cancer.
    J Obstet Gynaecol Res. 2025;51:e70022.
    

    >> Share

    
    
52. KITAJIMA K
    Updates and advances for gynecologic imaging.
    J Obstet Gynaecol Res. 2025;51:e70025.
    

    >> Share

    
    

    
    Lab Invest

53. GUO A, Yu Y, Guo Q, Zhang E, et al
    Potential Role of PARVB in Macrophage-Mediated Immunosuppression and Cervical Cancer Progression.
    Lab Invest. 2025 Jul 29:104223. doi: 10.1016/j.labinv.2025.104223.
    

    >> Share

    
    

    
    Lancet Infect Dis

54. AGBENYEGA T, Schuind AE, Adjei S, Antony K, et al
    Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.
    Lancet Infect Dis. 2025;25:861-872.
    

    >> Share

    
    

    
    Lancet Public Health

55. IWAMI M, Bouaddi O, Razai MS, Mansour R, et al
    Drivers of human papillomavirus vaccine uptake in migrant populations and interventions to improve coverage: a systematic review and meta-analysis.
    Lancet Public Health. 2025;10:e693-e711.
    

    >> Share

    
    

    
    Medicine (Baltimore)

56. HU S, Li Y, Hu M, Wang Z, et al
    Risk factors for hrHPV infection with cervical lesions patient in Anhui Province of China from 2021 to 2024: A retrospective study.
    Medicine (Baltimore). 2025;104:e43384.
    

    >> Share

    
    

    
    Neoplasia

57. ZHOU Q, Yu H, Dong A, Yi J, et al
    The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells.
    Neoplasia. 2025;67:101211.
    

    >> Share

    
    

    
    Nucleosides Nucleotides Nucleic Acids

58. ZHANG S, Shen X, Cui H
    Regulation of prognosis and tumor progression in cervical cancer by circ_0005728.
    Nucleosides Nucleotides Nucleic Acids. 2025.
    

    >> Share

    
    
59. WANG S, Wang J, Wang K
    LncRNA PCED1B-AS1 facilitates cervical cancer progression via targeting miR-361-3p.
    Nucleosides Nucleotides Nucleic Acids. 2025.
    

    >> Share

    
    

    
    Pathogens

60. GIANNELLA L, Grelloni C, Natalini L, Sartini G, et al
    Molecular Features of HPV-Independent Cervical Cancers.
    Pathogens. 2025;14:668.
    

    >> Share

    
    

    
    Pharmaceuticals (Basel)

61. NITTAYABOON K, Molika P, Bissanum R, Leetanaporn K, et al
    Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Modulate Chemoradiotherapy Response in Cervical Cancer Spheroids.
    Pharmaceuticals (Basel). 2025;18:1050.
    

    >> Share

    
    

    
    Pharmaceutics

62. LI J, Asat R, Li W, Parhat P, et al
    Molecular Target Identification of Gossypol Against Cervical Cancer Based on Target Fishing Technology.
    Pharmaceutics. 2025;17:861.
    

    >> Share

    
    

    
    PLOS Glob Public Health

63. MOHAMMED GEBABA E, Aweke GT, Addissie A, Assefa M, et al
    Factors affecting cervical cancer knowledge among women in Addis Ababa, Ethiopia: A population-based study.
    PLOS Glob Public Health. 2025;5:e0004961.
    

    >> Share

    
    

    
    PLoS One

64. MREMA A, Ngoma M, Lugina EL, Kahakwa A, et al
    Genotype distribution of human papillomavirus among women with cervical cancer stratified by HIV status in Tanzania.
    PLoS One. 2025;20:e0322311.
    

    >> Share

    
    

    
    Prev Med

65. BEGLARYAN H, Khattar J, Kassee C, Barrett K, et al
    Disability and receipt of the Papanicolaou test for cervical cancer screening: A systematic review and meta-analysis.
    Prev Med. 2025;199:108376.
    

    >> Share

    
    

    
    Prog Community Health Partnersh

66. STITES S, Kelly P, Glenn J, Smith S, et al
    Community-Engaged Research Informing Upstream Determinants of Cancer Prevention for People with Criminal Legal System Involvement.
    Prog Community Health Partnersh. 2025;19:227-235.
    

    >> Share

    
    

    
    Reports (MDPI)

67. HITOVA-TOPKAROVA D, Payakova V, Yordanov A, Kostova-Lefterova D, et al
    Locally Advanced Cervical Cancer in a Patient with Epidermolysis Bullosa Treated with Concurrent Chemoradiotherapy and Electronic Brachytherapy.
    Reports (MDPI). 2025;8:12.
    

    >> Share

    
    

    
    Reprod Health

68. LEBLANC ME, Line EC, Potter J, Goldman RE, et al
    Advancing equity in cervical cancer screening for sexual and gender minoritized people assigned female at birth (SGM AFAB) in the United States: recommendations from healthcare equity leaders.
    Reprod Health. 2025;22:135.
    

    >> Share

    
    

    
    Sci Rep

69. LIU J, Zhong M, Yang K, Wang J, et al
    Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix.
    Sci Rep. 2025;15:27827.
    

    >> Share

    
    
70. LAHDHIRI A, Benzina B, Ennaifer E, Tounsi H, et al
    HPV DNA screening and vaccination strategies in Tunisia.
    Sci Rep. 2025;15:27916.
    

    >> Share

    
    
71. LIU M, Luo Y, Song X, Mo R, et al
    Caerin 1.1/1.9 interfere KHDRBS1-DDX5 regulatory axis to induce IL-18 mediated pyroptosis in a HeLa cell tumour model.
    Sci Rep. 2025;15:27866.
    

    >> Share

    
    

    
    Spectrochim Acta A Mol Biomol Spectrosc

72. CHEN B, Yao X, Zhang S, Hu X, et al
    Highly sensitive detection of cervical cancer biomarker miR-21 using surface-enhanced Raman scattering (SERS).
    Spectrochim Acta A Mol Biomol Spectrosc. 2025;344.
    

    >> Share

    
    

    
    Ther Adv Med Oncol

73. WANG Z, Chu R, Wu N, Yuan M, et al
    Development and validation of prognostic prediction models for early-stage cervical cancer patients based on pathological intermediate-risk factors.
    Ther Adv Med Oncol. 2025;17:17588359251359461.
    

    >> Share

    
    

    
    Ther Adv Vaccines Immunother

74. HAMID MKI, Hasneen S, Lima AK, Shawon SR, et al
    Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.
    Ther Adv Vaccines Immunother. 2025;13:25151355251356646.
    

    >> Share

    
    

    
    Tumori

75. GUO X, Wang M, Yan S, Hu K, et al
    Clinicopathological characteristics and prognosis of cervical adenocarcinoma across diverse histological subtypes.
    Tumori. 2025;111:331-348.
    

    >> Share

    
    

    
    Virol J

76. SADEGHI Z, Aboofazeli A, Sarrafzadeh S, Tayebi N, et al
    Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centre.
    Virol J. 2025;22:264.
    

    >> Share

    
    

    
    Viruses

77. SCHICHL K, Doorbar J
    Regulation and Deregulation of Viral Gene Expression During High-Risk HPV Infection.
    Viruses. 2025;17:937.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share